One drug, one price, one discount
The product page carries a per-month figure with the higher list price struck through beside it, and states that the product is in stock and ready to ship. Its catalogue page runs a discount banner over the same product.
So the published figure is a discounted one, and what the product costs after the promotion is not published. There is no tirzepatide lane, no oral lane and no brand-name route.
Everyone named except the brand
Its legal pages name the clinical practice that prescribes and the platform company that runs the technology. Neither is the brand on the door.
The only corporate-form string we found on the host is a footer navigation label, which is a documented false positive and was rejected in context. The copyright line carries the brand with no corporate form after it.
This is a shape worth recognising: a consumer brand whose legal pages disclose its suppliers in full and itself not at all.
JulyMD's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $197/mo"From $297 $197/month · In stock and ready to ship", the higher figure struck through beside it; the catalogue page runs a "$100 OFF Semaglutide" banner over the same product | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 240 providers reviewed here are paid partners today; the other 236 are not. See how this works.
See JulyMD's current price →Good fit if
- Readers who want a semaglutide figure on the product page.
- Buyers who want the list price shown beside the discounted one.
- People who want to know which practice actually prescribes.
Look elsewhere if
- Anyone who needs the post-promotion price.
- Readers who want tirzepatide, an oral route or a brand-name option.
- Buyers who want the operating company named.
- People who need a pharmacy, clinician or service area named.
How this review was verified
- Re-read the homepage, the product page and the weight-loss collection on 7 September 2026, comparing requested to effective URLs with a nonsense path against the host in the same run, which returned a 404.
- Recorded the figure as a discounted one, because a site-wide banner runs over the same product.
- Read the single corporate-form hit in context, established it is a navigation label, and rejected it.
- Screened the brand against FDA’s live warning-letter datatable with both controls green in the same invocation.
- Re-fetched the warning letter: 200, with a title matching the brand, the reference number and the issue date, against a minted nonsense letter path that returned a 404 in the same run.